This webinar focused on:
> Fundamental principles for managing changes related to excipient manufacturing and supply
> The role of risk assessment in evaluating change
> Excipient manufacturer (maker) best practices and case studies for evaluating changes for level of significance
> Finished drug manufacturer (user) best practices and case studies for managing significant changes